Abstract
This review will focus on glutathione depletion performed in different biological systems to elucidate molecular implications of this tripeptide on physiological and pathological processes. Cellular and molecular changes produced in liver, brain and kidney by glutathione depleting drugs, such as D,Lbuthionine- S,R-sulfoximine, menadione and acetaminophen, will be described. Special attention will be given to the inhibitory mechanisms produced by those drugs on intestinal calcium absorption and alkaline phosphatase activity. The role of DL-buthionine-S,R-sulfoximine and menadione on mechanisms of apoptosis, reactive oxygen species production and mitochondrial function from mammalian breast cancer cells will be analyzed. Finally, reversion or prevention of some of the previous effects by administration of lipoic acid, glutathione monoester, KR31378 and 2(RS)-n-propylthiazolidine-4(R)-carboxylic acid will be discussed.
Keywords: glutathione, menadione, buthionine, sulfoximine, acetominophen, vitamin d, mcf cells, enterocytes, glutathione monoester, calcium absorption
Current Enzyme Inhibition
Title: Cellular and Biochemical Alterations Caused by Artificial Depletion of Glutathione
Volume: 1 Issue: 2
Author(s): N. Tolosa de Talamoni, A. Marchionatti, G. Diaz de Barboza and A. Perez
Affiliation:
Keywords: glutathione, menadione, buthionine, sulfoximine, acetominophen, vitamin d, mcf cells, enterocytes, glutathione monoester, calcium absorption
Abstract: This review will focus on glutathione depletion performed in different biological systems to elucidate molecular implications of this tripeptide on physiological and pathological processes. Cellular and molecular changes produced in liver, brain and kidney by glutathione depleting drugs, such as D,Lbuthionine- S,R-sulfoximine, menadione and acetaminophen, will be described. Special attention will be given to the inhibitory mechanisms produced by those drugs on intestinal calcium absorption and alkaline phosphatase activity. The role of DL-buthionine-S,R-sulfoximine and menadione on mechanisms of apoptosis, reactive oxygen species production and mitochondrial function from mammalian breast cancer cells will be analyzed. Finally, reversion or prevention of some of the previous effects by administration of lipoic acid, glutathione monoester, KR31378 and 2(RS)-n-propylthiazolidine-4(R)-carboxylic acid will be discussed.
Export Options
About this article
Cite this article as:
Talamoni Tolosa de N., Marchionatti A., Barboza Diaz de G. and Perez A., Cellular and Biochemical Alterations Caused by Artificial Depletion of Glutathione, Current Enzyme Inhibition 2005; 1 (2) . https://dx.doi.org/10.2174/1573408054022216
DOI https://dx.doi.org/10.2174/1573408054022216 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Serum HE4 Level as a Biomarker to Predict the Recurrence of Gynecologic Cancers
Current Drug Targets A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines
Current Drug Discovery Technologies Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research The Antimalarial Drug Pyronaridine Inhibits Topoisomerase II in Breast Cancer Cells and Hinders Tumor Progression In Vivo
Clinical Cancer Drugs Development of Folate-Conjugated PEGylated Poly (d,l-lactide-co-glycolide) Nanoparticulate Carrier for Docetaxel
Current Nanoscience Molecular Insight into the Inhibitory Mechanism of Galangin Towards Human Cytochrome P450 1A2. A Modeling Study
Letters in Drug Design & Discovery Gender Disparity in Pediatric Diseases
Current Molecular Medicine TGFß, a Potent Regulator of Tumor Microenvironment and Host Immune Response, Implication for Therapy
Current Molecular Medicine Nutraceutical: A Drug, Dietary Supplement and Food Ingredient
Current Pharmacogenomics and Personalized Medicine Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery
Anti-Cancer Agents in Medicinal Chemistry The Applicability of mTOR Inhibition in Solid Tumors
Current Cancer Drug Targets Can We Select Patients for Colorectal Cancer Prevention with Aspirin?
Current Pharmaceutical Design From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications
Current Topics in Medicinal Chemistry Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein
Current Cancer Therapy Reviews Design and Development of Oxazol-5-Ones as Potential Partial PPAR-γ Agonist Against Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Periplogenin Activates ROS-ER Stress Pathway to Trigger Apoptosis via BIP-eIF2α- CHOP and IRE1α-ASK1-JNK Signaling Routes
Anti-Cancer Agents in Medicinal Chemistry Is Type 2 Diabetes Mellitus a Predisposal Cause for Developing Hepatocellular Carcinoma?
Current Diabetes Reviews Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
Current Medicinal Chemistry Biomarkers, Critical Disease Pathways, Drug Targets, and Alternative Medicine in Male Breast Cancer
Current Drug Targets Multi-target Activities of Selected Alkaloids and Terpenoids
Mini-Reviews in Organic Chemistry